Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Consolidated Statements of Operations
Net Revenues	$ 106,786	$ 64,477
Operating Expenses
Cost of sales (excluding depreciation and amortization)	37,708	34,271
Research and development	5,924	5,274
Selling, general, and administrative	36,468	28,817
Depreciation and amortization	14,700	14,557
Contingent consideration fair value adjustment	961	753
Restructuring activities	1,130	0
Intangible asset impairment charge	0	0
Total Operating Expenses	96,891	83,672
Total operating income (loss)	9,895	(19,195)
Other Expense, net
Interest expense, net	(7,696)	(6,613)
Other expense, net	(34)	(89)
Income (Loss) Before Income Tax (Provision) Benefit	2,165	(25,897)
Income tax (provision) benefit	(726)	5,767
Net Income (Loss)	1,439	(20,130)
Dividends on Series A Convertible Preferred Stock	(406)	(405)
Net Income (Loss) Available to Common Shareholders	$ 1,033	$ (20,535)
Basic and Diluted Income (Loss) Per Share:
Basic Income (Loss) Per Share	$ 0.06	$ (1.27)
Diluted Income (Loss) Per Share	$ 0.06	$ (1.27)
Basic Weighted-Average Shares Outstanding	16,392	16,137
Diluted Weighted-Average Shares Outstanding	16,531	16,137